Literature DB >> 30738833

Frailty in multiple myeloma: the need for harmony to prevent doing harm.

Sonja Zweegman1, Alessandra Larocca2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30738833     DOI： 10.1016/S2352-3026(19)30011-0

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma.

Authors:  Thierry Facon; Ruben Niesvizky; Maria-Victoria Mateos; David Siegel; Cara Rosenbaum; Sara Bringhen; Katja Weisel; P Joy Ho; Heinz Ludwig; Shaji Kumar; Kenneth Wang; Mihaela Obreja; Zhao Yang; Zandra Klippel; Khalid Mezzi; Amanda Goldrick; Christina Tekle; Meletios A Dimopoulos
Journal:  Blood Adv       Date:  2020-11-10

2.  Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network.

Authors:  Gordon Cook; Alessandra Larocca; Thierry Facon; Sonja Zweegman; Monika Engelhardt
Journal:  Leukemia       Date:  2020-06-18       Impact factor: 11.528

Review 3.  Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects.

Authors:  Natasha Mupeta Kaweme; Geoffrey Joseph Changwe; Fuling Zhou
Journal:  Front Med (Lausanne)       Date:  2021-02-25

4.  Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.

Authors:  Faouzi Djebbari; Alexandros Rampotas; Fotios Panitsas; Wen Yuen Lim; Charlotte Lees; Ismini Tsagkaraki; Ana Rita Gomes; Steve Prideaux; Lucia Chen; Catherine Prodger; Akhil Khera; Nicola Gray; Lauren Ellis; Gina Sangha; Toby A Eyre; Sally Moore; Jaimal Kothari; Karthik Ramasamy
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240

5.  Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.

Authors:  Ho Sup Lee; JiHyun Lee; Jae-Cheol Jo; Sung-Hoon Jung; Je-Jung Lee; Dajung Kim; Sangjin Lee; Kevin Song
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

6.  Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysis.

Authors:  Smith Giri; Madan Raj Aryal; Han Yu; Alyssa Grimshaw; Ranjan Pathak; Scott P Huntington; Binod Dhakal
Journal:  J Geriatr Oncol       Date:  2020-06-05       Impact factor: 3.599
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.